Company news
Penumbra, Inc. news in 2026
Penumbra, Inc.'s news releases, calls and decks from 2026, newest first.
Penumbra, Inc. Reports Third Quarter 2026 Financial Results
October 29, 2026
Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
October 20, 2026
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
July 30, 2026
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care
July 22, 2026
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
July 7, 2026
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
June 15, 2026
Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
June 11, 2026
Penumbra, Inc. Reports First Quarter 2026 Financial Results
May 6, 2026
New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients
April 13, 2026
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
February 25, 2026
Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results
January 15, 2026
Decks in 2026
- Merger or Acquisition (January 2026)
Merger or acquisition · 11 slides · Jan 15, 2026